georgeclerkIn this article, I will outline why I think the high yielding pharmaceutical giant Pfizer (NYSE:PFE) looks bullish. Pfizer, known for Eliquis and Xeljanz, yields 5.57% and has a dividend safety rating of B- according to Seeking Alpha. I will outline my investment thesis using technical analysis tools such as price action, volume, momentum, and relative strength. I last wrote about PFE being bullish back in April 2021. Pfizer has since risen and then sold off considerably, so now I will take a ...